LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Differing kinetics of anti‐spike protein IgGs and neutralizing antibodies against SARS‐CoV‐2 after Comirnaty (BNT162b2) immunization

Photo by cdc from unsplash

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection has had a serious worldwide impact on human health. On December 2020, an immunization campaign with a COVID‐19 mRNA vaccine (Comirnaty‐BNT162b2 Pfizer‐BioNTech)… Click to show full abstract

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection has had a serious worldwide impact on human health. On December 2020, an immunization campaign with a COVID‐19 mRNA vaccine (Comirnaty‐BNT162b2 Pfizer‐BioNTech) was started in Italy, first targeting healthcare workers (HCWs). This study aims to investigate the antibodies that are response against SARS‐CoV‐2 vaccine.

Keywords: immunization; comirnaty bnt162b2; differing kinetics; sars cov

Journal Title: Journal of Applied Microbiology
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.